Suven Pharmaceuticals informs about outcome of board meeting

10 Feb 2021 Evaluate
Suven Pharmaceuticals has informed that the Board of Directors of the company, at its meeting held today February 10, 2021, approved the following along with other business matters: Took on record and approved the attached Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and nine months ended 31st December, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Reports of the Statutory Auditors. The Board has also declared an interim dividend of Re 1.00 per equity share of face value of Re 1 each for the year 2020-2021. The Board approved the Record Date, 18th February, 2021 notified by the Company for the purpose of payment of interim dividend to the eligible shareholders. The above said dividend will be paid on or before 11th March, 2021.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

542.20 -6.90 (-1.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×